Cleared Traditional

K142244 - CLEO PATIENT MONITOR

K142244 is an FDA 510(k) clearance for CLEO PATIENT MONITOR, manufactured by Infinium Medical. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 177-day FDA review.

K142244 · Infinium Medical · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 2015
Decision
177d
Days
Class 2
Risk

K142244 is an FDA 510(k) clearance for the CLEO PATIENT MONITOR. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Infinium Medical (Largo, US). The FDA issued a Cleared decision on February 6, 2015 after a review of 177 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K142244

510(k) Number K142244 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 2014
Decision Date February 06, 2015
Days to Decision 177 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d slower than avg
Panel avg: 125d · This submission: 177d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Ajw Technology Consultants, Inc.
JOHN O'BRIEN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 307
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K142244.
ViSi Mobile Monitoring System
K150361 · Sotera Wireless, Inc. · Apr 2015
AWARE
K143372 · Ambient Clinical Analytics · Apr 2015
T3 Software
K142732 · Etiometry, Inc. · Mar 2015
Visi Mobile Monitoring System
K143751 · Sotera Wireless, Inc. · Jan 2015
DECISIO HEALTH PATIENT DASHBOARD
K142106 · Decisio Health, Inc. · Jan 2015
Unity Network ID
K142840 · Ge Healthcare · Jan 2015